Evidence map›Paper›PMID 35059072›Full record

ArticleJournal of clinical medicine research2021

Hyperferritinemia Is a Predictor of Onset of Diabetes in Japanese Males Independently of Decreased Renal Function and Fatty Liver: A Fifteen-Year Follow-Up Study.

Yukie Sakuma, Jun Ogino, Rie Iwai, Takashi Inoue, Haruo Takahashi, Yoshifumi Suzuki, Daisuke Kinoshita, Koji Takemura, Hidenori Takahashi, Haruhisa Shimura and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical medicine research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Yukie SakumaClinical Research Support Center, Asahi General Hospital, Chiba, Japan.
Jun OginoDepartment of Diabetes and Metabolic Diseases, Asahi General Hospital, Chiba, Japan.
Rie IwaiDepartment of Clinical Laboratory, Asahi General Hospital, Chiba, Japan.
Takashi InoueClinical Research Support Center, Asahi General Hospital, Chiba, Japan.
Haruo TakahashiClinical Research Support Center, Asahi General Hospital, Chiba, Japan.
Yoshifumi SuzukiDepartment of Diabetes and Metabolic Diseases, Asahi General Hospital, Chiba, Japan.
Daisuke KinoshitaDepartment of Diabetes and Metabolic Diseases, Asahi General Hospital, Chiba, Japan.
Koji TakemuraDepartment of Diabetes and Metabolic Diseases, Asahi General Hospital, Chiba, Japan.
Hidenori TakahashiPreventive Medicine Research Center, Asahi General Hospital, Chiba, Japan.
Haruhisa ShimuraPreventive Medicine Research Center, Asahi General Hospital, Chiba, Japan.
Yasunori SatoDepartment of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
Shouji YoshidaDepartment of Internal Medicine, Asahi General Hospital, Chiba, Japan.
Naotake HashimotoPreventive Medicine Research Center, Asahi General Hospital, Chiba, Japan.
Asahi Hospital · JPKeio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes is an important health concern worldwide. The disease etiology may depend on multiple environmental and genetic factors that cause insulin resistance, including dysregulation of iron storage. The goal of this study was to examine the relationship of the serum ferritin concentration with onset of diabetes over a long period.

methodsCorrelations of serum ferritin and metabolic markers with onset of diabetes mellitus were examined over 15 years in 150 males participating in a health screening program.

resultsHOMA-β showed a gradual significant decrease in the first 4 years in subjects with ferritin > 190 ng/mL (group H) compared to those with ferritin ≤ 190 ng/mL, but there was no difference in HOMA-R between these groups. A significant number of cases with onset of diabetes was observed over 15 years (hazard ratio (HR): 3.97), and obesity, fasting blood glucose level, hemoglobin A1c (HbA1c), HOMA-R, fasting immunoreactive insulin (IRI) and C-peptide immunoreactivity (CPR) were all significant in univariate comparison between non-diabetes and diabetes-onset groups. In multivariate analysis, ferritin in group H (HR: 3.25), fatty liver (HR: 3.38), estimated glomerular filtration rate (eGFR) < 70 mL/min/1.73 m

conclusionsThese results suggest that the serum ferritin level is an important index for priority intervention in preventive medicine for reduction of onset of diabetes.

Indexed as

FerritinLong-term follow-upMalesType 2 diabetes

Identifiers

PMID35059072
PMCPMC8734509
OpenAlexW4200626649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.